Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
MicroRNA as Therapeutics for Age-Related Macular Degeneration
Riccardo Natoli1,2, Nilisha Fernando3
1John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia. riccardo.natoli@anu.edu.au.
Abstract:
MicroRNA (miRNA) are a class of endogenously expressed small non-coding RNA molecules that function by repressing or silencing post-transcriptional gene expression. While miRNAs were only identified in humans as recently as the turn of this century, some miRNA-based agents are already in Phase 2 clinical trials (Christopher et al. 2016). This rapid progress from initial discovery to drug development reflects the effectiveness of miRNAs as therapeutic targets. Further, their use as therapeutic agents in the treatment of diseases such as Alzheimer's disease (Wang et al. 2014) supports their use in other neurodegenerative diseases, such as Age-Related Macular Degeneration (AMD). However, despite ∼300 miRNAs reportedly expressed in the human retina (Xu 2009), relatively little research has been conducted into the therapeutic potential of miRNAs for the treatment of AMD. This review will investigate the use of miRNAs as therapeutic and diagnostic molecules for AMD.
Insights
MicroRNAs (miRNAs) show therapeutic potential for Age-Related Macular Degeneration (AMD). This review explores their use as diagnostic and therapeutic agents for AMD, a condition with limited current research in miRNA applications.
Area of Science:
- Biochemistry
- Genetics
- Ophthalmology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- miRNA research has rapidly advanced, with agents in clinical trials.
- miRNAs are effective therapeutic targets, evidenced by Alzheimer's disease treatments.
Purpose of the Study:
- To review the therapeutic and diagnostic potential of miRNAs for Age-Related Macular Degeneration (AMD).
- To highlight the under-researched application of miRNAs in retinal neurodegenerative diseases like AMD.
Main Methods:
- Literature review of existing research on miRNAs and AMD.
- Analysis of miRNA expression in the human retina.
- Exploration of miRNA-based therapeutic strategies.
Main Results:
- Approximately 300 miRNAs are expressed in the human retina.
- Limited research currently exists on miRNA's role in AMD.
- miRNAs show promise as therapeutic and diagnostic tools.
Conclusions:
- miRNAs represent a promising avenue for AMD treatment and diagnosis.
- Further research is warranted to explore miRNA's full potential in AMD.
- miRNA-based therapies could offer new hope for neurodegenerative eye diseases.
More Related Videos
08:54Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Therapeutic Index
The Effect of Aging on Tissues
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...